Manufacturer record
Suprex Laboratories: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Suprex Laboratories (Madhya Pradesh) were declared Not of Standard Quality between September 2021 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Suprex Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Tablets IP 500 mg | PCT-2445Mfg 2024-10 · Exp 2027-03 | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Paracetamol.Dissolution | RDTL, GuwahatiCDSCO lab | Dec 2025 |
| Loperamide Hydrochloride Tablets IP 2 mg. (LOMOCARE) | LCT-2009Mfg 2020-09 · Exp 2022-04 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.